About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us
More Company News
Avacta
Successful completion of fourth AVA6000 dose escalation
17 Jan 2023
Read More
Avacta
Avacta to host Therapeutics Division Science Day
19 Dec 2022
Read More
Avacta
Result of the Open Offer
08 Nov 2022
Read More
Avacta
Avacta to present at Theranostics FAP summit
31 Oct 2022
Read More
Avacta
Result of placing
18 Oct 2022
Read More
Avacta
Proposed placing, open offer and issue of convertible bonds
18 Oct 2022
Read More
Avacta
Proposed acquisition of Launch Diagnostics
18 Oct 2022
Read More
Avacta
Interim H122 results
29 Sep 2022
Read More
Avacta
US Orphan Drug designation for AVA6000
05 Sep 2022
Read More
Avacta
AVA6000 Phase I moves to fourth cohort
01 Sep 2022
Read More
1
2
3
4
Return to Avacta
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Redx Pharma
Scancell
Contact us